68 related articles for article (PubMed ID: 839073)
21. Comprehensive proteomics in yeast using chromatographic fractionation, gas phase fractionation, protein gel electrophoresis, and isoelectric focusing.
Breci L; Hattrup E; Keeler M; Letarte J; Johnson R; Haynes PA
Proteomics; 2005 May; 5(8):2018-28. PubMed ID: 15852344
[TBL] [Abstract][Full Text] [Related]
22. Studies on the chemical composition and biological properties of transfer factor.
Krohn K; Uotila A; Väisänen J; Gröhn P
Z Immunitatsforsch Immunobiol; 1977 Dec; 153(5):395-411. PubMed ID: 602344
[TBL] [Abstract][Full Text] [Related]
23. [Transfer of delayed type hypersensitivity in guinea pigs].
Smogorzewska E
Probl Med Wieku Rozwoj; 1990; 16():167-88. PubMed ID: 2152405
[TBL] [Abstract][Full Text] [Related]
24. Purification and analysis of a 5kDa component of enamel matrix derivative.
Mumulidu A; Hildebrand B; Fabi B; Hammarström L; Cochran DL; Dard M; Lemoult S
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 857(2):210-8. PubMed ID: 17689154
[TBL] [Abstract][Full Text] [Related]
25. Increase in E-rosettes after transfer factor (TF) treatment: fractionation of TF.
Khan A; Thometz D; Garrison O; Hill JM
Ann Allergy; 1976 May; 36(5):330-6. PubMed ID: 1084716
[TBL] [Abstract][Full Text] [Related]
26. Narrow-band fractionation of proteins from whole cell lysates using isoelectric membrane focusing and nonporous reversed-phase separations.
Zhu Y; Lubman DM
Electrophoresis; 2004 Apr; 25(7-8):949-58. PubMed ID: 15095432
[TBL] [Abstract][Full Text] [Related]
27. Concentration of murine antigen-specific transfer factor of defined potency.
Mayer V; Valásková M; Gajdosová E; Oravec C
Acta Virol; 1983 May; 27(3):228-37. PubMed ID: 6138984
[TBL] [Abstract][Full Text] [Related]
28. Flounder growth hormone: isolation, characterization, and effects on growth of juvenile rainbow trout.
Sakata S; Noso T; Moriyama S; Hirano T; Kawauchi H
Gen Comp Endocrinol; 1993 Mar; 89(3):396-404. PubMed ID: 8335228
[TBL] [Abstract][Full Text] [Related]
29. Human transfer factor in vitro: identification of L-serine and glycine as components with augmenting effect in lymphocyte transformation assay.
Uotila A; Marnela KM; Hamblin A; Krohn K
Scand J Immunol; 1978; 7(6):495-502. PubMed ID: 684376
[No Abstract] [Full Text] [Related]
30. Augmentation of 3H-thymidine incorporation by human lymphocytes in the presence of antigen and fractions of dialyzable transfer factor: a nonspecific phenomenon.
Littman BH; Hirschman EM; David JR
Cell Immunol; 1977 Jan; 28(1):158-66. PubMed ID: 64313
[No Abstract] [Full Text] [Related]
31. Human transfer factor: effects on lymphocyte transformation.
Burger DR; Vandenbark AA; Finke P; Nolte JE; Vetto RM
J Immunol; 1976 Sep; 117(3):782-8. PubMed ID: 956653
[TBL] [Abstract][Full Text] [Related]
32. Characterization of human macrophage activation factor (MAF) prepared from antigen-stimulated lymphocytes.
Cameron DJ
J Clin Lab Immunol; 1984 Jan; 13(1):47-50. PubMed ID: 6371237
[TBL] [Abstract][Full Text] [Related]
33. Comparative studies on tree-pollen allergens. I. Isolation and partial characterization of a major allergen from birch pollen (Betula verrucosa).
Apold J; Florvaag E; Elsayed S
Int Arch Allergy Appl Immunol; 1981; 64(4):439-47. PubMed ID: 7203648
[TBL] [Abstract][Full Text] [Related]
34. Purification and analysis of isoforms of soluble immune response suppressor (SIRS).
Webb DR; Mason K; Semenuk G; Aune TM; Pierce CW
J Immunol; 1985 Nov; 135(5):3238-42. PubMed ID: 4045193
[TBL] [Abstract][Full Text] [Related]
35. In vivo modification of delayed type hypersensitivity by small molecular weight components derived from human leucocytes: partial purification of components causing amplification of response.
Gottlieb AA; Sutcliffe SB
Clin Exp Immunol; 1982 Nov; 50(2):434-41. PubMed ID: 6185262
[TBL] [Abstract][Full Text] [Related]
36. UV-absorbance profile of human leukocytic ultrafiltrate after affinity chromatography on immobilized m-aminophenyl boronic acid: implication for transfer factor purification.
Borvák J; Mayer V
Acta Virol; 1985 Mar; 29(2):119-28. PubMed ID: 2860795
[TBL] [Abstract][Full Text] [Related]
37. Skin test conversion following transfer factor. A double-blinded study of normal individuals.
Neidhart JA; Christakis N; Metz EN; Balcerzak SP; LoBuglio AF
J Allergy Clin Immunol; 1978 Feb; 61(2):115-8. PubMed ID: 340492
[TBL] [Abstract][Full Text] [Related]
38. Transfer factor: hypoxanthine is a major component of a fraction with in vivo activity.
Tomar RH; Knight R; Stern M
J Allergy Clin Immunol; 1976 Jul; 58(1 PT. 2):190-7. PubMed ID: 956555
[TBL] [Abstract][Full Text] [Related]
39. Studies on the chemical nature of dialysable transfer factor. Comparison of human leukocyte dialysate and dialysates derived from human serum and from mammalian lymphoid and non-lymphoid organs.
Uotila A
Immunobiology; 1980 Jan; 156(4-5):353-63. PubMed ID: 7372348
[TBL] [Abstract][Full Text] [Related]
40. Transfer factor (TFd). Part I. Some physicochemical data.
Komorowska-Rycerz A; Szczypiorska D; Izdebska-Szymona K; Kociński W; Zarzycka A; Rzucidło L
Mater Med Pol; 1979; 11(4):317-9. PubMed ID: 553982
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
